ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12

SAN DIEGO, Aug. 5  /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that it will hold a conference call on Wednesday, August 12, 2009 at 1:30 p.m. Pacific (4:30 p.m. Eastern) to review financial results for the second quarter and provide an update on its business.

Individuals interested in listening to the conference call may do so by dialing [phone] for domestic callers, or [phone] for international callers, or from the webcast on the investor relations section of the Company's Web site at http://www.adventrx.com/.

A 48-hour telephone replay will be available approximately one hour after the conclusion of the call by dialing [phone] for domestic callers, or [phone] for international callers, and entering reservation code 23355569.  The webcast will be available on the Company's Web site for 14 days following the completion of the call.

About ADVENTRX

ADVENTRX Pharmaceuticals is a biopharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company's web site at http://www.adventrx.com/. 

DATASOURCE: ADVENTRX Pharmaceuticals, Inc.



CONTACT:  Brian Culley, Principal Executive Officer of ADVENTRX

Pharmaceuticals, [phone]; or Investors, Don Markley of

Lippert/Heilshorn & Associates, Inc., [phone], , for

ADVENTRX Pharmaceuticals



Web Site:  http://www.adventrx.com/ 

Copyright